[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"InnoVein\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":20,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100381952",false,"NCT04253301","Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency","Key Inclusion Criteria:\n\n* Willing and able to provide written Informed Consent\n* Diagnosis of symptomatic non-obstructive chronic valvular insufficiency of the femoral vein\n* Willing and medically able to receive intraprocedural and post-procedural anticoagulation medication\n* Life expectancy \\>1yr\n* Reflux time \\>1s in the superficial femoral and\u002For popliteal vein\n\nKey Exclusion Criteria:\n\n* Any prior deep vein intervention within 6 months prior to the Index Procedure\n* History of 2+ DVTs\n* Inadequate inflow to the femoral vein or inadequate outflow through the femoral vein, iliac vein, or IVC\n* Current IVC Placement\n* History of pulmonary embolism within 6 months\n* Conditions that increase the risk of device thrombosis or patient bleeding\n* Any planned surgical or interventional procedure within 30 days prior to or after the Index Procedure\n* Investigator or sponsor believes the subject would not benefit, would not be appropriate, be unable to follow-up, or be at high risk for non-compliance with the protocol","ALL","18 Years",{"count":17,"type":18},5,"ESTIMATED","INTERVENTIONAL",[21],"NA","This objective of this feasibility study is to evaluate the safety of the InnoVein Valve and Delivery System for treatment of chronic venous insufficiency.",[24],"Chronic Venous Insufficiency","RECRUITING","2021-09-15",{"date":28,"type":29},"2021-09-17","ACTUAL",{"date":31,"type":29},"2020-01-15",{"date":33,"type":18},"2027-01-15",{"name":35,"class":36},"InnoVein","INDUSTRY",3,""]